Follow-up at six months recorded updated HbA1c, BW, adverse events, and reasons for discontinuation
Deciding When to Stop or Taper Tirzepatide Therapy The decision to continue, maintain, or taper tirzepatide should be made with a healthcare provider and is based on three main factors: whether you've reached your weight goal, how stable your weight has been over recent months, and how confident you feel managing hunger and food choices without medication support
Many patients lose 1020% or more of their body weight over time when GLP-1 medications are combined with healthy nutrition, regular physical activity, and ongoing medical supervision
New obesity drug could change weight loss treatment For India, where long-term adherence is a major challenge, a once-monthly GLP-1 therapy could improve patient acceptance and sustained obesity management, says Dr Anoop Misra, Chairman at Fortis CDOC Hospital for Diabetes and Allied Sciences
Prescription eligibility is not guaranteed
This is typically administered via oral gavage or subcutaneous injection